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Abstract Many fungi have significant industrial applica-
tions or biosafety concerns and maintaining the original
characteristics is essential. The preserved fungi have to
represent the situation in nature for posterity, biodiversity
estimations, and taxonomic research. However, spontane-
ous fungal mutations and secondary metabolites affecting
producing fungi are well known. There is increasing
interest in the preservation of microbes in Biological
Resource Centers (BRC) to ensure that the organisms
remain viable and stable genetically. It would be anath-
ema if they contacted mutagens routinely. However, for
the purpose of this discussion, there are three potential
sources of biochemical mutagens when obtaining individ-
ual fungi from the environment: (a) mixtures of micro-
organisms are plated routinely onto growth media
containing mutagenic antibiotics to control overgrowth
by contaminants, (b) the microbial mixtures may contain
microorganisms capable of producing mutagenic second-
ary metabolites, and (c) target fungi for isolation may
produce “self” mutagens in pure culture. The probability
that these compounds could interact with fungi under-
mines confidence in the preservation process and the
potential effects of these biochemical mutagens are con-
sidered for the first time on strains held in BRC in this
review.
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Introduction
Microorganisms are often preserved in collections to better
ensure they represent wild-type strains from nature (Pater-
son et al. 2012). Many are kept to maintain applied and
biotechnological properties, although some may be pre-
served for properties unrelated to wild types such as trans-
formed strains. There are an estimated 1.5 to 3.0 million
fungal species (Hawksworth 2012), although only a small
number (ca. 75,000) have been isolated and named.
Some of those have high economic value, for example,
in relation to antibiotic, enzyme, and organic acid pro-
duction. Furthermore, internationally based culture collec-
tions are obliged to guarantee the authenticity of the
fungi they hold (Santos and Lima 2001), where the aims
are maintenance in a viable state without changing genes
(Ryan and Smith 2007).
Fifty years can be necessary for collections to become
world-recognized biological resource centers (BRC) (syn.
culture collections) (Wiest et al. 2012), requiring (a) manip-
ulation and preservation of individual isolates and (b) con-
comitant processing of thousands of isolates. Other
collections can also take lengthy and complex paths towards
development as BRC (Oh and Shin 2008; Smith and Ryan
2008). Best-practice guidelines have been developed by, for
example, the Organization for Economic Cooperation and
Development and the International Society for Biological
and Environmental Repositories, because many fungal re-
positories have similar objectives. These allow the success-
ful operation of collections and promote development and
interactions. Much improved preservation of fungi can be
obtained, for example, compared to that by individual lab-
oratories preserving strains in amateurish manners (e.g.,
cultures stored in the “back of the fridge”).
When microorganisms are isolated and preserved to de-
termine taxonomic relationships or to assess those present in
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the environment, it is assumed they are identical genetically
to those in nature. Indeed, it is sometimes stated that DNA
characters are preferable to others because they are “stable”
and independent of cultural conditions (Dupont 2009).
Paterson and Lima (2011) argued that this may not be the
case and that even these characters could be affected by how
the fungi are grown. Paterson et al. (2008) and Paterson and
Lima (2009) detail how growing cultures of fungi may result
in strains with mutated genes from the production of self-
mutagenic secondary metabolites.
Mutagens are physical or chemical agents that change
genetic material (usually DNA) of organisms and thus in-
crease the frequency of mutations above the natural back-
ground level. Mutations are accidental changes in a genomic
sequence of DNA and are caused by radiation, viruses, trans-
posons, mutagenic chemicals, and errors that occur during
meiosis or DNA replication. Fungi have been exposed con-
tinuously to UV radiation and many DNA⁄RNA damaging
agents for billions of years. Errors will occur during replica-
tion which damage DNA. Lesions could be (1) altered, miss-
ing, and mismatch bases, (2) deletion or insertion, (3) linked
pyrimidines, (4) strand breaks, and (5) intra- and inter-strand
cross-links (Fig. 1). DNA lesions can be retained, leading to
genome instability, mutations, carcinogenesis and/or cell
death. Secondary metabolites are microbial products that are
not essential for growth and reproduction of the producing
organisms. Each is formed by a limited number of species and
is encoded by sets of dispensable genes. These compounds are
(often) synthesized at the end of the exponential growth phase,
and their formation is highly influenced by the composition of
the culture medium. Concentrations of secondary metabolites
produced by fungi may increase beyond tolerable concentra-
tions in culture. In addition, proliferating cells may be more
mutable than quiescent because they have less time to repair
damage before DNA replication (Paterson and Lima 2009).
It is well known that fungi can be variable in culture and
spontaneous mutations occur: Wiebe (2002) discusses the situ-
ation with Fusarium species used to produce edible protein
substitutes. Mutants occurred often in relation to growth rates
and other physiological factors which could be secondary
metabolites produced by the fungi. Mutants of Aspergillus
parasiticuswere obtained simply by serial transfers (Wilkinson
et al. 2011). Furthermore, self-affecting compounds produced
in growthmedia are also reported (Singh et al. 2010), and so it is
reasonable to suggest that mutations may occur from the pro-
duction of self-produced metabolites, with profound implica-
tions in areas such as fungal preservation, phylogenetics, PCR
analysis, identifications, and taxonomy. Other factors which
could affect the fungi at preservation includes the methods
involved (e.g., freeze drying vs. cryopreservation (Broughton
et al. 2012)), UV irradiation, and other chemical compounds
encountered during preservation. However, these are beyond
the scope of the present review.
Consideration was given to the effects of biochemical
mutagens on preservation in an abstract and poster (Paterson
and Lima 2012) at the European Culture Collections' Orga-
nisation conference relating to BRC (Paterson et al. 2012). It
was stated that the possibility of cultures coming in contact
with mutagens is anathema to good practices in preserving
fungi, as the compounds could cause the fungi to mutate,
allowing them to become laboratory artifacts. This proba-
bility undermines confidence in the preservation process.
However, there are no papers published in journals on the
effects of these biochemical mutagens on fungi in collec-
tions whether of a hypothetical or factual nature, and this
review intends to redress the balance.
Sources of mutagens
1. Antibiotics to control contaminating microorganisms
Antibiotics are employed routinely to control the
growth of contaminating microorganisms when isolat-
ing fungi. For example, chloramphenicol or gentamicin
inhibit bacterial contaminants, while cycloheximide
inhibits saprobic moulds and are employed generally
Fig. 1 Diagrammatic representation of damage to DNA. Damage may
be from mutagenic secondary metabolites from a fungus leading to
changes in the DNA sequence. Epigenetic changes may occur leading
to problems with determinations of DNA base sequences to phenotypic
changes of the fungus (see Paterson and Lima 2009)
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in culture media during isolations. These compounds
are known to be mutagenic (Martelli et al. 1991;
Mitchell et al. 1980; Oliveria et al. 2011).
2. Secondary metabolites from co-isolated or target fungi
Microorganisms on the initial isolation agar plates,
and self (auto)-produced secondary metabolites by the
fungal isolate of interest, may mutate the target fungi,
especially after isolation in pure culture.
Numbers of mutagenic secondary metabolites
It is impossible to give an accurate figure for the total
number of these fungal compounds that exist in nature.
However, approximately 600 species produced 1,200 sec-
ondary metabolites (i.e., 2 per species) listed in Cole et al.
(2003). Some species are only given as the producers of one
compound, although others produce many more (e.g.,
Ganoderma lucidum has 76). Hence, often more than one
secondary metabolite needs to be considered in terms of
potential mutagens in culture media, as does the combined
effects of multiple mutagens. Cole et al. (2003) do not
include fungi from which no secondary metabolites have
been found and many of the other ca. 74400 of the known
fungi will not have been tested for mutagenicity which is
limited, in general, to a few species relevant to carcinoge-
nicity in humans and animals. Hence, there is no informa-
tion on the mutagenic potential of the vast majority of
secondary metabolites, although it is predictable that some
will be mutagens. For example, approximately 25 com-
pounds are listed in this review with mutagenic activity of
some manner. The current authors estimate that perhaps 100
compounds have some significance at present as mycotox-
ins and hence may have been expected to have been tested
for mutagenicity. Thus, the rate of positive results for muta-
genicity can be estimated as 25 %. The 75,000 known species
may produce 100,000 secondary metabolites as a conservative
figure, and so we estimate that 25,000 may be mutagenic. If
this is extrapolated to all fungi, then the figures become
125,000 to 250,000 mutagenic compounds. These figures at
least indicate that the number is large and the issue of self-
produced mutagens affecting fungi is important.
Mutagenic potential of mycotoxins in non-fungal systems
Mycotoxins with carcinogenic effects include aflatoxins,
sterigmatocystin, ochratoxin, fumonisin, zearalenone, citri-
nin, luteoskyrin, patulin, and penicillic acid produced by a
wide range of fungi (Table 1). Whether these compounds
will be self-mutagenic towards fungi remains unknown, but
it is possible: It appears axiomatic that they should be
avoided when preserving fungi. All are DNA damaging
agents except for fumonisins which may act via disturbing
signal transduction pathways (Paterson and Lima 2009,
2010). Some evidence for mutagenicity from fungi and
associated metabolites will now be considered.
Aflatoxins are the most carcinogenic natural compounds
known and avoiding contact is surely a priority when pre-
serving fungi. The mycotoxins are well known to be pro-
duced by Aspergillus flavus and A. parasiticus. They (1)
induce DNA damage, (2) affect negatively the amelioration
of damage, and (3) alter DNA base compositions of genes.
The mutagenicity of aflatoxin B1 has been demonstrated in
many systems. Aflatoxin B1 induces chromosomal aberra-
tions, micronuclei, sister chromatid exchange, unscheduled
DNA synthesis, chromosomal strand breaks, and forms
adducts in rodent/human cells. Furthermore, aflatoxins con-
taining an unsaturated terminal furan ring that can bind
Table 1 Selected mycotoxigenic fungi with some known mutagenic
mycotoxins detected from each (N.B. these are not necessarily the only
species capable of producing particular mycotoxins)
Filamentous fungi Mutagenic
mycotoxins
Alternaria alternata Altertoxin II
Aspergillus
A. carbonarius, A. westerdijkiae, A. niger Ochratoxin A
A. niger Fumonisins B2
and B4
A flavus, A. parasiticus
(11 other species can produce aflatoxins)
Aflatoxins
A. versicolor, A. flavus Sterigmatocystin
Chaetomium longicolleum Sterigmatocystin
Emericella nidulans (51 other fungal species
can produce sterigmatocystin)
Sterigmatocystin
Byssochlamys fulva, B. nivea Patulin
Fusarium
F. cerealis Nivalenol
F. culmorum¸ F. graminearum Deoxynivalenol,
Nivalenol
F. equiseti Zearalenone
F. poae Nivalenol
F. verticillioides (0 F. moniliforme),
F. globosum, F. nygami, F. proliferatum
Fumonisin B1
Penicillium
P. expansum Patulin, citrinin
P. verrucosum, P. nordicum Ochratoxin A
P. islandicum Luteoskyrin,
P. cyclopium Penicillic acid
P. paneum, P. brevicompactum Botryodiploidin
Mushrooms/toadstools
Lactarius sp., Russulaceae spp. Isovelleral
Lactarius necator Necatorin
Agaricus bisporus and related sp. Agaritine
Agaricus silvaticus. beta-Nitraminoalanine
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covalently to DNA forming an epoxide. One dose of afla-
toxin B1 to rats can cause a measurable increase in aflatoxin
B-DNA adducts that are increased after a second daily dose,
and hence the effects are rapid, with relevance to the time
used to grow fungi. Mutagenic sterigmatocystin has a chem-
ical structure similar to and is a precursor of, aflatoxins,
although it is produced by a wider range of fungi (Table 1).
Covalent binding to DNA and DNA adduct formation have
been reported, and it is carcinogenic to rats and mice in
which mainly liver tumors are induced.
Ochratoxin A is produced by several Aspergillus and
Penicillium species, including Aspergillus carbonarius, As-
pergillus westerdijkiae, and Penicillium verrucosum. The
secondary metabolite is one of the most potent carcinogens
in rats, and ochratoxin A is classified as a possible human
carcinogen by the International Agency for Research on
Cancer. Ochratoxin A induced DNA single-strand breaks
in cultured mouse and CHO cells. Adducts were found in
the kidney, liver, and spleen of mice treated with ochratoxin
A, and the DNA adduct level was dose-dependent and time
related. There is still insufficient understanding of whether
ochratoxin A acts as a direct genotoxic carcinogen or wheth-
er its carcinogenicity is related to indirect mechanisms. The
strongest evidence in favor of ochratoxin-mediated DNA
damage is the induction of DNA single-strand breaks and
formamidopyrimidine-DNA glycosylase sensitive sites.
Importantly, mutagenic activity by ochratoxin A has also been
reported (e.g., in murine cells). Ochratoxin-induced base sub-
stitutions were similar to those arising spontaneously, suggest-
ing that this mycotoxin increases the process involved in
spontaneous mutagenesis. Finally, the metabolite induces an
increase of mutation frequency at two gene loci via a mecha-
nism that is independent of biotransformation.
The concentration necessary to induce DNA–DNA cross-
links by patulin are in the millimolar range and the induction
of DNA–DNA cross-links is a possible mechanism of the
mutagenicity observed. The compound is produced by a
wide range of species within Aspergillus, Penicillium,
Byssochlamys, and Paecilomyces. However, patulin may not
reach the nucleus to cause damage because of its high reac-
tivity with proteins, and cell-free reactivity might not occur in
cellular systems. The direct reactivity of patulin towards DNA
in a cellular system has been demonstrated and mutations of
cells might be from an indirect mutagenic mechanism (e.g.,
inhibition of enzymes) (Paterson and Lima 2009).
The genotoxic risk associated with deoxynivalenol
(Table 1), a prevalent trichothecene mycotoxin, has not yet
been explored thoroughly. The Comet assay was used to
evaluate DNA damage stemming from deoxynivalenol ex-
posure, and dividing cells were found to be more sensitive
than differentiated cells. The results demonstrated the exis-
tence of a genotoxic potential for deoxynivalenol at low
concentrations compatible with actual exposure situations
(Bony et al. 2006). Nivalenol damaged the nuclear DNA of
CHO cells demonstrating that it is a direct mutagen
(Paterson and Lima 2009). DNA damage appeared in the
kidney and bone marrow of mice after oral dosing, and
nivalenol showed organ-specific genotoxicity in mice relat-
ed to time and intensity as a direct mutagen. Nivalenol and
fusarenon X caused DNA damage after 24 and 72 h expo-
sure in Caco-2 cells, and damage was observed dose-
dependently with relevance to growing fungi in culture for
even short periods. Furthermore, fusarenon X increased
DNA strand breaks in dividing cells. The Fusarium grami-
nearum metabolite zearalenone showed a positive DNA
damaging effect in recombination tests with Bacillus sub-
tilis. The compound also induced (1) polyploidy in CHO
cells, (2) sister chromatid exchange, and (3) chromosomal
aberration in vitro. Furthermore, treatment of mice led to the
formation of several DNA adducts in the liver and kidney
(Paterson and Lima 2009). Fusarin C is mutagenic and is
produced from Fusarium moniliforme. Unidentified com-
pounds NG-391 and NG-393 from Fusarium spp. were also
detected from fermentation extracts of the entomopathogenic
and possible biocontrol fungus Metarhizium anisopliae.
They are 7-desmethyl analogues of fusarin C and (8Z)-
fusarin C, mutagenic toxins from fusaria of corn. However,
like their fusarin analogues, the compounds exhibited potent
S9-dependent mutagenic activity (Krasnoff et al. 2006).
Furthermore, 41 fungal isolates (one isolate per species)
representing common plant pathogens and food crop con-
taminants were assayed for mutagenic activity. Extracts of
two aflatoxin-producing isolates (A. flavus and A. parasit-
icus) showed pronounced mutagenic activity, as did extracts
of five other species (Aspergillus heterothallicus, Aspergil-
lus nidulans, Aspergillus terricola, Alternaria tenuis, and F.
moniliforme) which (unsurprisingly) did not contain detect-
able aflatoxins. Seven additional isolates (Botrytis cineria,
Ceratocystis fimbriata, Cladosporium herbarum, Fusarium
solani f. sp. pisi, Penicillium oxalicum, Thermomyces lanu-
ginosus, and Verticilium albo-atrum) revealed activity
which was possibly mutagenic (Bjeldanes et al. 1978).
An extract of Alternaria alternata was mutagenic as were
isolated compounds altertoxins I, II, and III with and with-
out metabolic activation (Stack and Prival 1986). Altertoxin
II (ATX II) has a perylene quinone structure and is at least
50-times more potent as a mutagen than the common Alter-
naria toxins alternariol (AOH) and alternariol methyl ether
(AME) (Fleck et al. 2012). However, the mutagenic poten-
cies of several A. alternata toxins seem unable to account
for the levels of activity found using crude mycelial extracts
of this fungus. Hence, the mutagenic effects of nitrosylation
were examined with the major Alternaria metabolites alte-
nuene (ALT), AOH, AME, altertoxin I (ATX I), tentoxin
(TENT), tenuazonic acid (TA), and radicinin (RAD). In the
absence of nitrosylation, ATX I was mutagenic, while AOH
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and ATX I were weakly mutagenic. Incubation with nitrite
generally increased mutagenic potencies with ATX I being
strongly mutagenic, while ALT, AME, and RAD responses
were enhanced in one test. However, subsequent examination
of three extracts made from A. alternata culture broth showed
a different mutagenic response with broth and acetone washes
being directly mutagenic in some cases. Thus, while nitro-
sylation increases the mutagenicity of ATX I, and to a lesser
extent that of several other Alternaria toxins, the results dem-
onstrate that Alternaria produces a major mutagenic activity
with a Salmonella typhimurium response different from that
found with the purified toxins (Schrader et al. 2001).
DNA repair synthesis was elicited by several compounds
of unknown carcinogenicity, 5,6-dimethoxysterigmatocystin,
versicolorins A and B, averufin, xanthomegnin, luteosporin,
and chrysazin, and by the carcinogenic mycotoxins, aflatoxin
B1, sterigmatocystin, luteoskyrin, and ochratoxin A. The pos-
itive results with compounds of unknown carcinogenicity at
the time of the study, suggested that they are genotoxic carci-
nogens (Mori et al. 1984). In addition, botryodiploidin is listed
as mutagenic and produced by Penicillium paneum and Pen-
icillium brevicompactum (Frisvad et al. 2004).
Intermediates in the aflatoxin biosynthetic pathway were
screened for their mutagenic activity. Norsolorinic acid, aver-
ufin, and versiconal acetate were found to possess questionable
mutagenic activity, but versicolorin A and sterigmatocystin
were significant mutagens relative to aflatoxin B1. The muta-
genic activity appeared to be related to the bisfuran and not the
anthraquinone moiety of the molecule, even although the latter
is a key structure of such a potent carcinogenic mycotoxin as
luteoskyrin (Wong et al. 1977). Furthermore, extracts of A.
nidulans and an Aspergillus fumigatus strains were determined
to have mutagenic properties by Bubak et al. (1996).
Finally, extracts of 37 of 48 species of mushrooms
exhibited significant mutagenic activity, and six metabolites
reported to occur in some of the species were also tested.
Mushrooms are potential foods and can be grown on agars
or similar substrates in mycelial form for the purposes of
preservation and so are relevant to the discussion. Signifi-
cant mutagenic activity was found from (a) isovelleral from
Lactarius sp., (b) agaritine from Agaricus bisporus and
related sp., and (c) beta-nitraminoalanine from Agaricus
silvaticus. Furthermore, isovelleral may be a major mutagen
in some of the sharp-tasting and mutagenic Russulaceae
species. A. bisporus was weakly mutagenic and agari-
tine was also weakly active: This fungus might contain
other mutagenic material. Beta-nitraminoalanine was not
found in the A. silvaticus tested, and the mutagenicity
observed may therefore be due to other metabolites
(Sterner et al. 1982). Extracts of Lactarius necator
exhibit considerable mutagenic activity, and a highly
mutagenic compound, necatorin, was isolated (Liu
2005).
Finally, lack of information on other mycotoxins and
indeed secondary metabolites in general, should not be
interpreted as a statement on the mutagenicity of these
agents. In fact, the aflatoxin literature at least serves as a
model for subsequent research into other secondary metab-
olites (Paterson and Lima 2009).
Concentrations of secondary metabolites in media
In general, mycotoxins accumulate to a high level in growth
media. Aflatoxin B1 ranged from 1.4 to 4 μgml−1 in A. para-
siticus or A. flavus, and 60 μgml−1 of aflatoxin B1 was detected
from A. flavus in yeast extract sucrose (YES) broth. Yeast
extract peptone was the non-inducing medium and would be a
logical choice for preserving these fungi by avoiding the muta-
gen. Ochratoxin A was estimated at 0.5 mg20 ml−1 in YES
from Aspergillus alliaceus, and paxilline accumulates at very
high levels in growth media from Penicillium paxilli. Penicilli-
um griseofulvum produced nearly 2 mgml−1 of patulin after
96 h in a potato dextrose broth, which was much higher than for
the other species tested, and approximately 3 mgml−1 was
detected from P. expansum on Czapeks Dox agar (Paterson
and Lima 2009). All Fusarium culmorum strains tested pro-
duced DON/3-AcDON at levels ranging from 21 to
11,000 μgg−1 of dry biomass onMycotoxin Synthetic medium
(Kammoun et al. 2010). Paterson (2007) even found 15 ngl−1
of ZEN produced in water byF. graminearum. Hence, it is well
known that fungi grown on standard growth media can pro-
duce high levels of mycotoxins.
Egigenetic alterations
In addition, epigenetic alterations are possible when pre-
serving fungi (Fig. 1) as these also have been reported in
other non-fungal systems: More work is required on the
epigenetic effects of fungal metabolites. For example, the
mechanisms of fumonisin carcinogenicity do not appear to
involve interaction with DNA and the carcinogenic activity
of fumonisins may be mediated via epigenetic mechanisms
(Coulombe 1993). Fumonisin B1 induced hypermethylation
of DNA (Mobio et al. 2000) and may be involved in histone
modifications (Pellanda et al. 2012). Ochratoxin A also has
epigenetic effects (Marin-Kuan et al. 2008) and is likely to
act through a network of interacting epigenetic mechanisms,
including protein synthesis inhibition, oxidative stress, and
the activation of specific cell signaling pathways, which are
responsible for carcinogenicity. Low, but sustained levels of
chronic oxidative stress can result in cell proliferation ulti-
mately converting DNA damage into mutations, leading to
cell transformation, and, in relation to our discussion, to
mutated fungal strains. Finally, aflatoxin B1 preferably
binds to methylated lysines or modified histones leading to
DNA damage via these epigenetic mechanism (Herceg
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2007). How are the above discussions relevant to preserva-
tion and biodiversity estimations?
Mutagens may affect preservation and biodiversity
estimations
Figure 2 indicates how isolates may be affected by mutagens
during initial isolations from the natural environment, where
many different organisms can be co-isolated which may
produce secondary metabolites. For example, aflatoxins
are the most carcinogenic natural compounds known, and
fungi that produce these compounds are isolated quite fre-
quently in nature. Admittedly, the concentrations of second-
ary metabolites may be low as the target isolates are
removed quickly from the media; on the other hand, there
could be a complex mixture of compounds from all the
organisms isolated on the agar. The mutagenic load is higher
when the antibiotics included in the media are also consid-
ered, which are at high concentrations. Hence, a mutant may
already have been isolated instead of the desired wild type.
Isolates are grown on media before preservation to check
purity and to obtain identifications when self-produced
mutagens or epigenetic compounds may also be produced
(Paterson and Lima 2009; Paterson et al. 2008). These
compounds can be produced at high concentrations and
may inhibit mechanisms involved in reducing toxicity such
as transportation in vesicles, detoxification by enzymes, and
compartmentalization (see Paterson and Lima 2009). Spe-
cifically, enzymes involved in detoxification (Hansen et al.
2011) may be inhibited by enzyme inhibiting secondary
metabolites produced by the fungi. The strains will be
preserved subsequently but may be laboratory artifacts.
Similarly, mutagenic secondary metabolites may be pro-
duced when fungi are grown from preservation for mainte-
nance, analyses, or sale leading to further mutations (Fig. 3).
Hence, the strain could have been subjected to a wide range
of mutagens before it is even used for the analysis for which
it was intended. This may be unproblematic if it is being
used to produce a particular compound (e.g., citric acid), as
the genes involved in the biosynthetic pathway may not be
affected by the mutations. However, if the stains are being
employed in large scale gene sequencing (Andersen et al.
2011) or used in a taxonomic study involving DNA analy-
sis, then this could indeed be problematic.
Biodiversity
A corollary of the above argument is that estimations of
fungal biodiversity (see Hawksworth 2012) may be inaccu-
rate from mutations of strains during isolation and culture. If
isolates of different species from nature are subjected to
mutagens, then they may result in more similar strains
which could be mistakenly identified as the same species
(Fig. 4). Conversely, different isolates from the same species
in nature may mutate to become increasingly different be-
cause of the effects of mutagens (Fig. 5). Hence, there
would be an underestimation and overestimation of diversi-
ty respectively, and care needs to be taken to ensure that
these two scenarios do not occur.
1st Mixed isolation 1st Pure culture Preservaton (e.g. 
Lyophilisation)
Mutagenic
Metabolites 
+ antibiotic
Self
Mutagenic
Metabolites or
Mutant Mutant
Wild-type Wild-type
Wild-type 
or 
Mutant?
or
Fig. 2 Exposure to mutagenic compounds during isolation. The initial
isolation from nature involves spreading a mixed culture onto an
isolation medium. In this situation, many secondary metabolites may
be produced by the various organisms present and the isolate of interest
may be subjected to self-produced metabolites
Preserved Spread plate Single colony
culture
Self 
Mutagenic 
Metabolites
Self
Mutagenic
Metabolites
or or Etc.
Wild-type
Mutant
Wild-type
Mutant
Fig. 3 Exposure to mutagenic metabolites from re-growth. When an
isolate is re-grown from preservation, it may come in contact with self-
produced mutagenic secondary metabolites leading to undesired
changes to the wild-type fungus
Hyphae of 3 
species in vivo
No mutagens
Mutagens a,b,c
Mutagens x,y,z
Wild type
Colonies for 
preservation
Mutant 1 
Mutant 2
Fig. 4 Artificial decrease in biodiversity from mutagens. This is
represented by three different species in the environment being made
more similar by mutation when cultured in vitro and appearing to be
three isolates of a single species
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Patulin-producing potential—an example of the problem
The mutagenic effect of secondary metabolites on the DNA of
the producing fungi in pure culture was first postulated by
Paterson (2004), when it was realized that inhibitory and
mutagenic secondary metabolites could determine whether
isolates were positive or negative for possession of the idh
gene of patulin biosynthesis (a mycotoxin and antibiotic). For
example, it was impossible to state with certainty that the
isolates represented those in nature because some had been
in contact with patulin in culture, which is mutagenic: these
and the other isolates tested, had also been subjected similarly
to different self-produced secondary metabolites (Paterson
and Lima 2009; Paterson et al. 2008). The work was under-
taken at a large public BRC where the strains had been
accessed, given strain numbers and preserved as detailed in
the paper. Furthermore, the fungi employed had been in
contact with antibiotics to control other microorganisms dur-
ing isolations, hence increasing the mutagenic load on the
target organisms. It was impossible to state that the preserved
strains were representative of the fungi in the orchard and may
have been laboratory artifacts (Paterson and Lima 2012).
Equivalent methods to those described above have been
employed routinely by many other workers.
Solutions
Solutions to this problem of experimental design are somewhat
difficult to conceive. A literature search is at least required as to
which secondary metabolites are known to be produced by the
taxa of interest, as some are known to produce many secondary
metabolites whilst others produce few. Some precautions can
sensible be employed such as decreasing the concentration of
antibiotics in isolation media if this is possible without over-
growth by contaminants. Also, the time period in which isolates
are grown could be perhaps be reduced, but often the growth
periods are part of standard methods, and changing these times
could have detrimental consequences. The number of subcul-
tures needs to be minimized. A consideration of which growth
media are employed is required to ensure that the secondary
metabolites are minimized (see section Concentrations of sec-
ondary metabolites in media). However, often particular media
are prescribed for characterizing taxa, and changing media may
cause unforeseen problems. The use of physical barriers to the
media (e.g., cellulose-based, pressure sensitive adhesive tape
(e.g., sellotape) may be useful, which separate the isolates from
the media, although the production of intracellular metabolites
will remain a problem and metabolites may be able to cross the
barrier. It would be desirable to preserve the substrates from
which the isolates were obtained to enable the re-isolation of the
fungi, although this would increase the space requirements of
BRC considerably, and the target fungus may not be able to be
re-isolated from certain substrates.
A logical approach would be to grow the fungi in such a
manner that the metabolites are not produced. This is clas-
sical fungal physiology where growth (i.e., trophophase) is
distinct from the secondary metabolite production phase
(i.e., idiophase) (Paterson and Lima 2009). Trophophase is
usually linked to exponential growth of the fungus where
biomass increases rapidly. Secondary metabolite production
can commence often when a nutrient such as the nitrogen
source is depleted. These phases are defined in stirred batch
bioreactors using liquid media rather than agar plates of
course. However, mutagenic metabolites could be avoided,
at least in some cases, by choosing an appropriate growth
phase at which to harvest mycelium.
Finally, fungi should be grown for various time periods and
on different media to determine the effects on DNA sequen-
ces, and it is surprising that this type of work has not been
performed routinely. The cultures would require analysis for
secondary metabolites simultaneously, and there are numer-
ous methods for analyzing secondary metabolite profiles of
strains ranging from TLC to HPLC UV/MS (Nielsen and
Smedsgaard 2003). All the above areas require further work
to obtain data which unequivocally demonstrates that muta-
genic metabolites are reduced or eliminated. Also, data from
individual strains will probably not be applicable to all fungi,
and work on the particular fungi of interest will be required.
Conclusions
Steps require to be taken to ensure strains from nature do not
become laboratory artifacts and the present, unprecedented
collaboration between culture collections (Paterson et al.
2012) provides a unique platform to ensure that authentic
microorganisms are obtained and preserved. Work is re-
quired on (a) the mutagenic effects of such compounds on
Hyphae of 3 isolates 
of 1 species in vivo
No mutagens
Mutagens a,b,c
Mutagens x,y,z
Wild type
Mutant 1
Mutant 2
Colonies  for 
preservation
Fig. 5 Artificial increase in biodiversity from mutagens. This is rep-
resented by three different isolates of the same species in nature
appearing to give three different species when cultured in vitro
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strains and (b) how to avoid them. Finally, it is essential to
be able to state with confidence that fungi in BRC are not
laboratory artifacts.
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